Trial intelligence / Profile preview

Synchro-Neb: In Vitro Nebulizer Comparison

NCT02084043Completed

Sponsor
Cliniques universitaires Saint-Luc
Start
Mar 2014
Primary completion
Jun 2015
Countries
1
01

Overview

Trial (2 arms), sponsored by Cliniques universitaires Saint-Luc. Primary endpoint: Inhaled dose at 24 hours. Started Mar 2014; status: completed.

Beyond the preview

Go deeper on NCT02084043.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02084043.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call